Patent · US Expired

R(-)3-quinuclidinol derivatives

US5164386A · kind A · utility

8Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 1990
Grant dateNov 17, 1992
Priority date
Expiry dateJun 20, 2010

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmacologically active R(-) 3-quinuclidinol derivatives are described which are muscarinic receptor blocking agents useful for the treatment of gastrointestinal and respiratory tract disorders of the following formula (I) ##STR1## wherein R represents a linear or branched lower alkyl group, a cycloalkyl-C.sub.1-2 alkyl or an aralkyl group, or it is absent; PA0 X represents the anion of an organic or inorganic acid, or it is absent, when R is absent; PA0 R.sub.1 represents H, a linear or branched lower alkyl group or an acyl group of the type R.sub.2 --CO, in which R.sub.2 is H or a linear or branched lower alkyl group; PA0 A represents a cycloalkyl, an aromatic ring or a 5- or 6-membered heterocyclic ring; PA0 Y and Z may be simultaneously or alternatively present or absent; when they are simultaneously present, they represent oxygen; when only one of them is present, it is oxygen or sulphur; PA0 n is 1, 2 or 3; PA0 A and the 3-quinuclidinyl ester groups are inserted simultaneously on the same carbon atom of the ring to give rise to a geminal substitution. The process for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are al…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.